[Trump's FDA pick](https://www.cnbc.com/2026/08/19/trump-picks-heidi-overton-lead-fda.html) is a medical doctor with domestic policy experience, not a pharma executive. Markets are reading this as a green light for faster drug approvals. That's the wrong trade. The real edge is in companies selling AI and diagnostic infrastructure *into* healthcare systems — not pharma itself.